DrugPatentWatch Database Preview
DUOPA Drug Profile
Which patents cover Duopa, and what generic alternatives are available?
Duopa is a drug marketed by Abbvie Inc and is included in one NDA.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for DUOPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 3 |
| Patent Applications: | 31 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DUOPA |
| DailyMed Link: | DUOPA at DailyMed |
Pharmacology for DUOPA
| Drug Class | Aromatic Amino Acid |
Synonyms for DUOPA
| (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid |
| 500019-90-9 |
| 57308-51-7 |
| AC1L2XHE |
| Carbidopa / Levodopa |
| CARBIDOPA AND LEVODOPA |
| Carbidopa Levodopa |
| Carbidopa mixture with Levodopa |
| Carbidopa-L-dopa mixt |
| Carbidopa-L-dopa mixt. |
| Carbidopa-levodopa (1:10) |
| Carbidopa-levodopa ER |
| Carbidopa-levodopa extended release |
| Carbidopa-levodopa mixt |
| Carbidopa-levodopa mixt. |
| carbidopa, levodopa drug combination |
| CHF 1512 |
| Co-careldopa |
| CR-3 |
| CR-5 |
| DM-1992 |
| Dopabain |
| Duodopa |
| IPX 066 |
| IPX066 |
| Isicom |
| IVTMXOXVAHXCHI-YXLMWLKOSA-N |
| L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid |
| L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1) |
| Levodopa / carbidopa |
| levodopa carbidopa |
| Levodopa-carbidopa (10:1) |
| Levodopa/Carbidopa Solution |
| LS-158296 |
| Nacom |
| Nakom |
| ND 0612 |
| ND0612 |
| Rytary |
| SCHEMBL2049245 |
| Sinemet CR |
| Sinemet CR4 |
US Patents and Regulatory Information for DUOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | DUOPA | carbidopa; levodopa | SUSPENSION;ENTERAL | 203952-001 | Jan 9, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
